Filing Flows › bioAffinity Technologies (BIAF) › Histology Service Fees revenue
bioAffinity Technologies (BIAF) Histology Service Fees revenue by quarter
bioAffinity Technologies' Histology Service Fees revenue was $190K in Q3 2026 (third quarter 2026), -24% from Q2 2026. Over the last 6 quarters it ranged from $190K (Q3 2026) to $289K (Q4 2025).
| Quarter | Histology Service Fees revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $190K | -24% | -26% |
| Q2 2026 | $248K | -0.9% | — |
| Q1 2026 | $251K | -13% | -5% |
| Q4 2025 | $289K | +13% | — |
| Q3 2025 | $256K | -3% | — |
| Q1 2025 | $264K | — | — |
Q3 2026 at a glance
bioAffinity Technologies, Q3 2026: revenue $1.1M (-26% year over year), operating margin -328.0%, net loss $5.3M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is bioAffinity Technologies' Histology Service Fees revenue?
bioAffinity Technologies' Histology Service Fees revenue was $190K in Q3 2026 (third quarter 2026), -24% from Q2 2026.
How has bioAffinity Technologies' Histology Service Fees revenue changed?
Over the last 6 quarters it ranged from $190K (Q3 2026) to $289K (Q4 2025).
Q3 2026 results → · How bioAffinity Technologies makes money →